Trump's lawsuit against Wall Street Journal over Epstein story dismissed for now-May 2024-www.financetom.com

Trump's lawsuit against Wall Street Journal over Epstein story dismissed for now

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Trump's lawsuit against Wall Street Journal over Epstein story dismissed for now

Apr 13, 2026 6:41 AM

April 13 (Reuters) - A U.S. judge dismissed on Monday

Donald Trump's defamation lawsuit against the Wall Street

Journal over an article asserting the U.S. president's name was

on a 2003 birthday greeting for the late financier and sex

offender Jeffrey Epstein, but said Trump could re-file the

case.

Previous page： Assembly Biosciences Prices $100 Million Offering Next page： Market Chatter: KKR-Backed OHB and KNDS Mull Changes to Share Sale Timeline Amid SpaceX IPO

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Assembly Biosciences Prices $100 Million Offering

May 22, 2026

07:40 AM EDT, 05/22/2026 (MT Newswires) -- Assembly Biosciences ( ASMB ) said Friday it has priced an underwritten, registered offering of 3,358,602 shares at $26.50 per share and pre-funded warrants to purchase up to 415,000 shares at $26.499 per warrant, for gross proceeds of approximately $100 million. Certain investors will buy the pre-funded warrants in lieu of common stock,...

Market Chatter: KKR-Backed OHB and KNDS Mull Changes to Share Sale Timeline Amid SpaceX IPO

May 22, 2026

07:45 AM EDT, 05/22/2026 (MT Newswires) -- KKR-backed (KKR) space company OHB and weapons manufacturer KNDS are considering moving their planned share sales to avoid a clash with SpaceX's (SPCX) initial public offering in the United States, Bloomberg reported Friday, citing people familiar with the matter. Both OHB and KNDS had plans to commence their offerings on June 12, the...

Top Premarket Decliners

May 22, 2026

07:42 AM EDT, 05/22/2026 (MT Newswires) -- Futu ( FUTU ) and UP Fintech ( TIGR ) shares were down 38% and 37%, respectively, in Friday premarket activity after China's securities regulator said the companies could face penalties for operating in mainland China without licenses. NervGen Pharma ( NGEN ) stock was 33% lower after the company priced an offering...

Regeneron Says Otarmeni Application Accepted Under EU Accelerated Assessment

May 22, 2026

07:38 AM EDT, 05/22/2026 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) said Friday the European Medicines Agency has accepted for accelerated assessment its marketing authorization application for Otarmeni to treat OTOF-related hearing loss. The gene therapy, previously known as DB-OTO, targets biallelic OTOF variant-associated hearing loss, the company said. The therapy received accelerated approval in the US in April,...